Antibody-mediated modulation and redirected lysis assays demonstrated the capacity of NKp30 and, to a lesser extent, NKp44, but not NKp46, to enhance Vδ1+ T cell cytotoxicity against tumor cell targets (11). This evidence concerns the gene NCR3 and neoplasm.